babycord-one-years-stemmatch-combo-product

Preserve baby’s precious stem cells, find stem cell match for baby.

babycord (1 year) + StemMatch

Utilize the lifesaving power of your baby’s stem cells and get a chance to find stem cell matches for baby.Get unlimited community registry access for your immediate family members who could be in need of a stem cell transplant

  • Sample Type: Umbilical Cord Blood
  • Results: 15 Days (Initial Results) + FREE Annual Updates
  • Collection By: Doctor
  • Parameters Tested: 19 (Cord Blood) + 8 HLA Markers

What’s in the Combo?

GenomeScope x 1 | Family Floater x 1

It’s not just your baby you’re blessed with but also with what comes attached with it as it could be the lifeline for a loved one who could be in need of stem cells for transplant

With Family Floater; your siblings, their spouses, as well as their children can enjoy the life-saving benefits of community banking and get access to the largest registry of Indian origin stem cells without needing to have a baby themselves.

  • What’s Included?
    All LifeCell community banking members who wish to share the protection of community stem cell banking to their extended family’s health can now do so at a very affordable price and without necessarily needing to have made a personal contribution themselves to the community.
  • Why Choose Family Floater?
    It is a once in a lifetime chance for your extended family members to benefit from the opportunity of having access to a pristine and precious source of stem cells which has several advantages compared to other sources.
  • Treatable Conditions
    Over 50,000 stem cell transplants occur worldwide each year for treatment of 90+ conditions approved currently, and the researchers are continuing to investigate its use in several more indications.
How does it work?

Order Online

Enroll for GenomeScope Newborn test along with babycord or book a standalone test online.

Sample Collection

A trained paramedic collects the blood sample either via heel-prick or through the cord blood soon after the baby’s birth.

Receive Digital Results

Within 21 days, you’ll receive the results and useful insights on your personalised dashboard.

Follow Up

  • If tested positive, schedule a virtual consultation with our genetic counsel - or to understand your results better.
  • If tested negative, consult a physician for further testing. Exome re-analysis is recommended in case of future presentation of symptoms.
Digital Results - Your Smart Report

Customised Dashboard Experience:

Along with an interactive, user-friendly experience, we also offer you the complete screening test insight in the form of smart reports.

SMART Reports

Empowering you with the right information, our SMART reports are:

  • Easy-to-understand
  • Reliable
  • Easy to share in just a few clicks!

Recommendations from Genetic Counselors

We understand the importance of receiving expert advice at the right time. That’s why we don’t just provide your test results and leave it at that. Our in-house team of genetic counselors interprets the out-of-range results and provides you with tailored advice.

Why choose LifeCell?

NABL & CAP Certified

Our labs are NABL and CAP certified. This means they have to meet high testing standards and submit themselves to regular inspections.

Privacy & Confidentiality

Your privacy is our priority. We use state-of-the-art technology to ensure your data is stored securely, and under no circumstance do we ever sell your data.

Certified Results

All our test reports are reviewed & approved by board-certified geneticists and genetic counselors.

Hear From Our Doctors And Customers

Frequently Asked Questions

Wish To Know More?

Signs and symptoms of genetic conditions can be visible from birth or may develop over time. And when these symptoms appear, it can take an average of 2 to 3 misdiagnoses, 8 physicians, and between 5.6 to 7.6 years before arriving at an accurate diagnosis. This misdiagnosis or delay in identifying a condition can lead to severe complications, including premature death and lifelong disability.

The GenomeScope Newborn test identifies such genetic conditions before any signs or symptoms manifest. Insights from the test can enable timely intervention that paves the way for proactive healthcare decisions as well as an informed future.

A genetic test is the only possible way to detect the risk of your baby suffering from a genetic condition. These statistics throw light on the fact that rare genetic conditions are becoming more common globally, including in India.

  • There are 7000 known rare diseases.
  • At any point in time, they affect 263 to 446 million people all over the world.
  • 80% of these rare diseases have a genetic origin, with half of them targeting children.
  • With an ever-growing population and prevalence of consanguinity, rare genetic diseases have become a public health burden for India.
  • Heart conditions like Aortic aneurysms & Cardiomyopathies
  • Blood conditions like Beta Thalassemia, Fanconi Anemia
  • Hereditary childhood cancers like Wilms tumor, Retinoblastoma
  • Neurological conditions like Neurofibromatosis Type 1, Autism spectrum disorder
  • Endocrine Conditions like Hypothyroidism, Adrenal hyperplasia
  • Immune Conditions like SCID, Chronic granulomatous disease
  • Kidney Conditions like Polycystic kidney disease, Hyperoxaluria
  • Metabolic Conditions like Krabbe disease, Mucopolysaccharidosis Type 3
  • Other conditions like Muscular dystrophy, Hearing Loss, optic atrophy Type 1

The term newborn screening refers to screening newborns for treatable inherited conditions soon after birth. It is a biochemical screening test that helps to screen babies for close to 50 severe-but-treatable conditions. It requires additional confirmation via genetics, which may require an extra sample and more time, causing interim anxiety.

Also, missed diagnosis may lead to overall increased poorer outcomes. GenomeScope Newborn, on the other hand, is an advanced genomic test that offers a broader view of conditions that may not be identifiable by blood biochemistry.

Rare genetic conditions have become a common public health concern in India, implying the need for effective and adequate genetic testing services. Taking this into account, in 2019, the Department of Biotechnology (DBT) launched the UMMID Initiative - The Unique Methods of Management and Treatment of Inherited Disorders. The UMMID initiative has a clear goal to establish NIDAN (National Inherited Diseases Administration) Kendras across Govt. hospitals in the country that will provide services like counseling, prenatal testing, diagnosis, and management for rare genetic conditions.

Talk To Our Experts, We Are Here To Help

Curious To Learn More About Our Products Or Not Sure Where To Begin Your Journey?

Featured Blog